Icon

KYXATA - (20MG/2ML, 80MG/8ML, 500MG/50ML)

CARBOPLATIN None
20MG/2ML, 80MG/8ML, 500MG/50ML
Less Than $1000 mn
None None
None None
None None
KYXATA is a platinum-based drug indicated in adults: • As part of a combination regimen, for the initial treatment of advanced ovarian carcinoma. • As a single-agent for the treatment of ovarian carcinoma recurrent after prior chemotherapy.
Yes
KYXATA Patent 1
*** *********

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.